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Abstract: Presented studies were conducted to assess the influence of alternating (AC) and/or static 
(DC) magnetic fields (MF) or combined with puromycin (PMC) on U937 cell line viability. The magni-
tude of DC MF was enclosed in the range (2 ÷ 6) mT. In case of AC MF, four frequencies were set: 
12 Hz, 25 Hz, 35 Hz, 50 Hz and magnetic induction value was adjusted to 6.5rms mT. The reaction 
of samples exposed to MF and/or PMC was presented as cell viability coefficient S defined as a ra-
tio of viable cells in the sample to viable cells in the relevant control sample, analyzed by flow 
cytometry. For PMC treated sample the percentage of viable cells decreased about factor 3. MF 
alone did not influence cell viability regardless of the type of exposure while simultaneous action of 
ACDC MF mode and PMC significantly influenced viability of U937 cells. The viability coefficient S was 
in the range of (0.13 ± 0.07 ÷ 0.64 ± 0.20) and exerted a non-linear relation with frequency of the 
AC MF component. The maximal lethal influence (S = 0.13 ± 0.07) was observed for DC MF = 6 mT 
and frequency of AC MF equal to 35 Hz. Observed bio-effects were confronted with the physical models 
assuming the Ca2+ ions transport disturbance and/or protein complexes dysfunction in cells due to 
MF action.
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INTRODUCTION
Technology development, increasing use of electrical appliances in a daily life 
causes widely distribution of magnetic fields (MF) in our environment. At the 
same time, epidemiological studies have indicated a rise of different types of hu-
man cancer, particularly of hematological malignancies [1, 2]. On the other hand 
therapeutic role of MF is also presented in the context of magnetotherapy [3]. 
Therefore, the question about the influence of MF on living organisms remains 
relevant and still open. Despite many studies [4–13], biophysical mechanism of 
interaction between MF and biological systems is not fully understood. Attempts 
to explain observed bio-effects based on developed non-thermal mechanisms have 
been noted difficult and unclear. Results of experiments are dependent not only 
on MF parameters, but also on biological material properties [11]. 
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So far, studies have been mainly based on various cell lines due to their po-
tential simplicity as biological objects. Many factors can induce cell death, in-
cluding electromagnetic irradiation as well as chemical stimulation. Cell death 
can occur by two distinct mechanisms, apoptosis (“programmed” cell death) and 
necrosis (“accidental” cell death). These processes differ each other in many ob-
servable morphological and biochemical changes in the cells [14] what can be 
favorable to distinguish between viable and non-viable (damaged) cells using the 
flow cytometry, for instance.
Presented studies were conducted to assess possible influence of alternating (AC) 
and/or static (DC) magnetic fields or combined with cytotoxic agent on U937 hu-
man lymphoid cell viability. U937 cell line was investigated as an in vitro model for 
antitumour testing or tumorigenicity. In previous studies three ranges of MF flux 
densities were most frequently examined (50–100 mT, 15–20 mT and 45–50 mT) 
[3, 15, 16], hence we decided to complete existing data about DC MF set in the 
range (2 ÷ 6) mT. Additionally, in case of AC MF component, the amplitude was 
selected to relate with parameters used in magnetotherapy and to compare ob-
tained data with results of other groups [13].
MATERIALS AND METHODS
CELL CULTURE
U937 cells (human lymphoid cell line; ATCC, Rockville, MD) were cultured in 
RPMI 1640 medium (Gibco-BRL, USA) supplemented with 10% (v/v) heat-inac-
tivated fetal bovine serum (Gibco-BRL, USA), 0.2 M L-glutamine and 50 mg/ml 
gentamicin (Sigma-Aldrich, Germany) at 37oC in humidified atmosphere con-
taining 5% CO2. U937 cells were passaged every four days and counted with 
a Fuchs-Rosenthal chamber. The experiments were performed on viable cells 
assessed by trypan blue exclusion method, in the logarithmic phase of growth. 
For the experiment U937 cells were seeded into 6-well culture plates at density 
2.5 × 105 cells/ml. In order to place cells in MF exposure device, cells were col-
lected to BD Falcon polystyrene test tubes. Cells were harvested and washed with 
fresh medium after each stimulation. Procedure was verified to obtain the best 
accuracy and reproducibility.
CHEMICAL STIMULATION
Cells were supplemented with PMC, a known unselective cell death inducer acting 
via inhibition of translation in protein synthesis process [17, 18], at concentration 
of 100 μg/ml (Sigma-Aldrich, Germany). Puromycin was applied simultaneously 
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with MF exposition to stimulated samples and separately added to PMC control 
sample. After particular treatment cells were harvested and washed with fresh 
medium, resuspended at initial volume and finally analyzed for viable/damaged 
cells contribution. Chemical stimulation was performed in a form of single (2.5 h) 
or triple (3 × 2.5 h) repetition with 24 h intervals.
ExPOSURE SYSTEM
Measurements were performed in a few steps. Cells were exposed to homogenous 
DC MF alone or combined with perpendicularly oriented sinusoidal component. 
The magnitude of DC MF component ranged from 2 mT to 6 mT. In case of corre-
spondent AC MF, four different frequencies were set: 12 Hz, 25 Hz, 35 Hz, 50 Hz 
and magnetic induction value was adjusted to 6.5rms mT. The exposition was re-
peated (1 ÷ 3) times (by 2.5 h each one) with 24 h intervals.
The MF in user defined mode (AC MF, DC MF or ACDC MF) were produced 
by specially designed Helmholtz coils (HC). Tubes containing U937 cells were 
positioned in the center of the coils. The coils with exposed samples as well as 
control ones were maintained in an incubator. During exposure to MF, tempera-
ture inside the coils was kept at 37 ± 0.1oC.
The homogeneity of the MF in the sample volume was tested and ensured with 
the accuracy of a few% by using the Gaussmeter equipped with Hall probe. Con-
trol samples were set in area out of MFs produced by HC (the background mag-
netic field for static and alternating components was as follows: < 0.05 ± 0.01 mT 
and < 0.03 ± 0.01 mT, respectively). In the first step, the frequency (50 Hz) of 
AC MF was chosen in a view of wide abundance of 50 Hz MF sources. Another 
three values of frequencies were set to establish potential resonant behaviour of 
the exposed samples.
DETECTION SYSTEM
Cell viability was estimated with a BD FACSCalibur (San Jose, CA) flow cytometer 
equipped with a 15-mW 488-nm blue argon ion laser and with a 10-mW 635-nm 
red diode laser. U937 cells were stained with Annexin V-APC labeled (BD Bio-
sciences, USA) and with 7-amino-actinomycin D (7-AAD; BD Biosciences, USA) 
in order to distinguish between viable cells and cells affected by cell death pro-
cesses (damaged), by analyzing the fluorescence intensity of these dyes. Annex-
in V-APC and double-positive Annexin V-APC and 7-AAD cells were analyzed as 
damaged ones. Viable population was registered as Annexin V-APC and 7-AAD 
negative. Staining was performed on cells cultivated for 24 h, after last puromy-
cin and MF stimulation. CellQuest Pro software (BD, San Jose, CA) was used to 
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analyze the percentage of viable/non-viable cells. Number of events collected for 
each sample was no less than 104 to obtain reliable statistics. The details of the 
applied experimental procedure are given elsewhere [19].
STATISTICS
Results are presented as a viability coefficient S, defined as a ratio of viable cells 
in the sample exposed to MF alone or in combination with PMC (MF + PMC), 
to viable cells in the relevant control sample (sham one or only PMC treated). In 
case of experiments with the use of cytotoxic agent alone, the percentage of viable 
cells in the sample was used to assess results. Viability coefficient S was estimated 
as the mean of no less than six experiments (± standard deviation). Statistical 
analysis was performed by U-Mann Whitney and Kruskal-Wallis test considering 
P < 0.05 as significant.
RESULTS
Data analysis has shown that magnetic fields alone did not influence the U937 
cell line viability. Even AC+DC components combination did not change this 
effect considerably, regardless of used DC MF magnitude (2 mT or 6 mT) and 
frequency selection (12 Hz, 25 Hz, 35 Hz, 50 Hz) in case of 6.5rms mT AC MF, 
as well as number of exposure repetitions (1 ÷ 3). Viability coefficient S was en-
closed in the range (0.98 ± 0.02 ÷ 1.01 ± 0.02) for various modes of the mag-
netic field exposure.
Application of PMC influenced the U937 cell viability. Effects depended on 
dosage, time of stimulation, time of detection and sample processing, as estab-
lished by test measurements. The percentage of viable cells in the samples varied 
in the range (0.20 ± 0.1 ÷ 93.5 ± 0.5)%. For further studies the parameters of 
PMC application causing decrease of the viable cells percentage in the sample to 
about 30% were chosen. It was related to 100 µg/ml as a dose applied in triple 
repetition (3 × 2.5 h) with 24 h interval between applications.
Combination of DC MF and PMC did not provoke cell viability changes in the 
samples. Viability coefficient S was equal to 1.11 ± 0.05. Similar results were 
observed for the most abundant 50 Hz AC MF (S = 1.04 ± 0.05).
However, simultaneous action of ACDC MF and PMC significantly influenced 
the U937 cell viability in the samples (Fig. 1). The viability coefficient S was en-
closed in the range (0.13 ± 0.07 ÷ 0.64 ± 0.20) and showed a non-linear relation 
with used frequencies of the AC MF component. The maximal lethal influence 
(S = 0.13 ± 0.07) was observed for the following parameters of magnetic fields: 
DC MF = 6 mT, AC MF = 6.5rms mT and f = 35 Hz. It indicates that alternating 
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and static magnetic field combination could amplify changes caused by cytotoxic 
agent, leading to cell death more effectively. For most abundant frequency (50 Hz), 
amplification of cell death processes was about 4 times less compared to the 
minimum (Fig. 1).
Fig. 1. Changes of viability coefficient S in accordance with frequency f of alternating magnetic 
field component (DC MF = 6 mT and AC MF = 6.5rms mT). Data expressed as mean  SD (n  6).
DISCUSSION
Obtained results showed that magnetic fields alone did not significantly influ-
ence U937 cell viability, regardless of used magnetic flux densities, frequencies, 
as well as chosen modes of the MF exposure. Foregoing findings are consistent 
with conclusions of some other groups [5, 11, 12], although the other studies sug-
gest growth inhibition of selected human tumor cell lines exposed to MF [10, 20]. 
Existing controversies revealed dependence between caused effects and type of 
cells [7, 9, 11, 21].
Chemical stimulation with puromycin induces cell death through disturbance 
of protein synthesis process. Effectiveness of its action varies with applied dosage, 
time-course of application and type of cells [22]. In the present work, threefold 
application (3 × 2.5 h) with 24 h interval between applications of PMC in high 
dose (100 mg/ml) dramatically changed percentage of U937 viable cells in the 
sample compared to sham one.
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Combination of MF with action of different chemical agents, PMC for instance, 
can also influence cell viability in a different ways. As an example, in [13] au-
thors showed no changes in the number of rat lymphocytes with DNA damage 
exposed only to 7 mT DC MF. However, simultaneous exposure of cells to FeCl2 
and 7 mT DC MF or 50 Hz 7rms mT AC MF caused significant increase of the 
damaged cells population due to possible radical pairs mechanism.
Results presented in our work revealed that combination of DC MF or AC 
MF (50 Hz) and PMC did not influence the U937 cell viability in the samples. In 
case of DC MF, its protective role against PMC — induced cell death according 
to some authors [8, 11, 23] was not confirmed. Mentioned discrepancy is proba-
bly due to some differences in experimental conditions (density of cells, cytotoxic 
agent dosage, time of chemical stimulation, etc.). Unobservable effect for AC MF 
+ PMC stays in contrast with our previous work [19], where simultaneous ac-
tion of 50 Hz pulsating electromagnetic field (PEMF) with PMC on the same 
cell line viability was examined. However, described protective role of PEMF 
against PMC — induced cell death was obtained for the much higher (45 ± 
5 mT) amplitude of used MF compared to present paper and for different signal 
waveform.
In turn, simultaneous action of ACDC MF mode and PMC increased number 
of damaged U937 cells. The viability coefficient S changed in non-linear way with 
used frequencies of the AC MF component, obtaining minimum for 35 Hz. Where-
as, tests with three times lower magnitude of DC MF component were ineffective, 
no changes in cell viability were noticed. It seems to indicate also BAC/BDC ra-
tio dependency of the observed bio-effects [24, 25] and requires further studies.
To explain differences between data obtained by various scientific groups one 
has to note that simple comparison is not trivial or maybe even not possible for 
many reasons. Firstly, observed effects are strictly dependent on applied MF pa-
rameters such as amplitude, frequency, signal waveform, as well as dose and 
type of used chemical drug. Secondly, sensitivity to external stimulation varies 
for different types of cells. Another crucial point is matched time of chemical 
and/or physical stimulation and interval between exposition and further detec-
tion. Finally, chosen detection method and way of samples processing may also 
influence the results [26].
Our findings indicate a range of MF parameters and details of cytotoxic agent 
application appropriate to influence U937 cell viability due to simultaneous action 
of physical and chemical factors. Synergy of MF and PMC determines changes in 
studied system, which finally could provoke biochemical signal cascades devel-
opment. Energy of used MF is not enough to cause lethal lesions in the cell in 
direct way [4, 25, 27]. Thus, cytotoxic agent is needed firstly to decrease the “nat-
ural cellular defense mechanisms”. Puromycin, accomplished this role through 
disturbance of protein synthesis process, what finally can lead to deregulation 
of intracellular signal pathways.
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In cellular signaling not only peptides are involved but also key biological ions 
(e.g., Ca2+) [28]. The Ca2+ ions play an important role as signaling molecules in 
cells, what corresponds to their intracellular concentration maintained through 
different mechanisms (pump, channels, proteins) [29]. For instance, action of 
some signaling proteins depends on Ca2+ ions binding, the same time maintaining 
low concentration of Ca2+ ions in the cytoplasm (0.1 ÷ 0.2 mM) [30, 31]. Thus, 
deregulation of protein formation process can influence Ca2+ homeostasis and 
Ca2+-dependent signaling pathways in the cell [32–40]. Initiated perturbations 
at the level of biochemical signaling in the cell might lead to more frequent and 
easier cell death upon exposure to external MF, for instance.
Basic problem is related to indicate the biophysical mechanism(-s) respon-
sible for observed changes in cell viability caused by MF action on “chemically 
weaken” cell. Concerning physiological role of Ca2+ ions, the findings are mainly 
focused on physical models assuming mechanisms generating the ionic trans-
port disturbance and/or ion-protein complexes dysfunction in cells due to MF. 
Three physical models: ion cyclotron resonance (ICR), free ions’ forced-vibration 
mechanism (FIFVM), and mechanism of magnetosomes motion in magnetic fields 
were used to confront presented results.
ION CYCLOTRON RESONANCE
The ICR model was used to interpret bioactivity of low-frequency MF combined 
with low-magnitude DC MF [41–44]. The interpretation of ICR model for bio-sys-
tems is based on the assumption that ion-protein complex in the cell proclaims 
harmonic oscillator with many vibrational energy levels. Applied DC MF with mag-
nitude BDC causes Zeeman splitting of energy level E into two sublevels (E1, E2) 
with energy difference equal to 
 
c
DC hf
m
qB
h =)
2
(
π
 [45]. Additional exposure to AC MF 
can influence the probability of ion-protein complex transitions between energy 
states that depends on Bessel function argument [46]. Bioactivity of the ion-pro-
tein complex depends on its spatial configuration related to energy state of the 
complex. Thus, applied ACDC MF can finally lead to changes in cell signaling. 
Calmodulin with bound Ca2+ ions sets an example of bioactive “ion-protein” com-
plex in the cells [31].
Considering ICR model, molecular masses of hypothetical elements of a bio-
chemical complex which could interact with magnetic fields were estimated. As-
suming BDC = 6 mT, fc = 35 Hz and q = (1 ÷ 10) e, calculated molecular masses 
are enclosed in the range (2.7 ÷ 27) kDa. Many proteins playing a crucial phys-
iological role in the cell have similar masses. At this stage of studies it was im-
possible to determine a particular complex existing in the U937 cell.
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FREE ION’S FORCED-VIBRATION MECHANISM
Proposed mechanism [47] was based on the assumption that observed bio-effects 
in the cells exposed to external oscillating electromagnetic field (EMF) can be ex-
plained through ion’s forced-vibration, caused by applied field. Once amplitude 
of the ion’s forced-vibration exceeds some critical value, the oscillating electric 
charge can influence an electro-sensitive ion channels gating, thus disrupting 
cellular electrochemical equilibrium and cell function.
To confront discussed model with results obtained for AC MF and ACDC MF 
action on U937 cells only magnetic fields will be further considered. Under as-
sumption of certain physical properties of the cell, Panagopoulos D.J. et al. pre-
sented relation between ion oscillating amplitude and displacement rj necessary 
to disturb electro-sensitive ion channel gating:
      
where l — attenuation coefficient for the ion movement; 
B1 — AC MF amplitude; 
u — ion velocity; 
q — ion charge; 
w — angular frequency of the AC MF.
Estimated values of rj are equal to 4 ·10
–12 m and 2 ·10–12 m for single- and 
double-valence cations inside the ion channel, respectively. Results obtained for 
AC MF (6.5rms mT; f = 50 Hz) were confronted with FIFVM model for key biological 
Ca2+ ions. Made calculations assuming l @ 10–12 kg/s and u = 0.25 m/s indicated 
2.3 × 10–12 m as an oscillating amplitude for Ca2+ ion. It meant that relation (1) 
was hardly fulfilled for used AC MF, hence the possibility of ion channel gating 
modulation and further changes in U937 cell viability were doubtful. Above cal-
culations stay in accordance with our observations, no bio-effects were noticed.
Considering results obtained for used static (with magnitude BDC) and alter-
nating magnetic field combination (ACDC MF), relation (1) modifies to: 
     
The dependence between ion oscillation amplitude and frequencies from the 
range (10 ÷ 100) Hz is presented in Fig. 2 for Ca2+ ion. It is well seen that rela-
tion (2) for 6 mT DC MF combined with 6.5rms mT AC MF was fulfilled in a full 
range of tested frequencies (12 ÷ 50) Hz. Thus, performed estimations indicated 
possibility of the ion channel gating modulation through Ca2+ ion forced-vibration. 
It stays in agreement with results presented in Fig. 1, where changes of the vi-
ability coefficient S upon ACDC MF action, were experimentally proved.
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In case of applied ACDC MF, the ion movement is more complex due to super-
position of two movements forced by DC MF and AC MF, respectively. Thus, the 
involvement of strong enough DC MF might also influence the electro-sensitive ion 
channels gating. For three times lower magnitude of DC MF and 50 Hz AC MF 
an oscillating amplitude was comparable with the one obtained for AC MF acting 
alone and was not enough to cause any changes in U937 cells.
Fig. 2. Oscillation amplitude for Ca2+ ion vs. frequency of alternating magnetic field component.  
B1 = 9.2 mT and BDC = 6 mT; l @ 10
–12 kg/s; u = 0.25 m/s. In the hatched region oscillation  
amplitudes for Ca2+ ion follow the relation (2). Dashed line corresponds to rj  = 4  10
–12 m.
The FIFVM model does not determine a full interpretation of MF influence 
on U937 cell line viability, particularly in the context of S(f) non-linearity (Fig. 1). It 
mainly arises from difficulties to define appropriate values of parameters used 
in the ion movement equation. Unknown value of ion oscillation circular self-fre-
quency w0 and assumption that l >> w0 exclude analysis of resonant effects.
Nevertheless, basing on the FIFVM model, the calcium ions likely influence 
on the ion channel gating this way triggering biochemical signal cascades leading 
to changes of U937 cell line viability.
MAGNETIC FIELDS ACTION ON MAGNETOSOMES
Bioactivity of magnetic fields was also interpreted in a frame of MF action on parti-
cles with non-zero magnetic moment (magnetosomes) [48]. This type of structures, 
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built up from magnetite crystals, were found in a variety of human tissues and 
some leukemic cell line [49]. Magnetosome with magnetic moment µ placed in 
the static magnetic field BDC, will tend to align with the direction of this field. If 
additional alternating magnetic field B1sinwt is applied, the magnetic moment 
will be reoriented vs. BDC direction (at an angle q). Inasmuch the magnetic 
moment reorientation takes a place in the viscous medium, there are three 
torques on the magnetosome, which limit its movement [27].
Nevertheless, the magnetosome rotational motion alone does not explain the 
cell reaction to MF action. Some authors suggested the possible linkage between 
rotation of magnetosome and gating of mechanically sensitive ion channels. The 
proposed mechanism involves the role of the cell cytoskeleton [50].
Considering parameters of used ACDC MF and according to formulas for rota-
tional viscous drag coefficient and for magnetic moment of a single-domain mag-
netosome [51–53], the radius of a potential magnetosome necessary to produce 
an effective magnetosome-induced cytoskeletal tension leading to the ion channel 
activity was estimated as ≥ 11 nm. 
Nevertheless, the value of magnetosome rotation angle (an important variable 
of quotation used in the model) varied little with the used range (12 ÷ 50) Hz of 
MF frequency. This did not correspond with the frequency-related results (Fig. 1) 
obtained in the experiments. Thus, S(f) dependence obtained for U937 cell line 
cannot be explained by mechanism involves magnetosomes, even such particles 
would be found in the cells.
CONCLUSIONS
The results exhibited that ACDC MF may influence U937 cell viability in the 
presence of puromycin, in contrast to action of magnetic fields alone. Basing on 
made estimations in a frame of tested models, we conclude that observed bio-ef-
fects are probably caused by perturbations of calcium ions transport through ion 
channels, what further could trigger changes of Ca2+ ions concentration in the 
cell compartments. Puromycin as used chemical agent could also influence Ca2+ 
ions intracellular distribution, but on the chemical way [28]. Therefore, we sup-
pose that simultaneous action of ACDC MF and PMC led to cell death through 
deregulation of calcium dependent cell signaling pathways.
The results confirmed that further studies on static and low-frequency mag-
netic fields influence on U937 cells or other suchlike cell lines would be required 
to find biophysical mechanism(-s) explaining particular effects.
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